Skip to main content
Clinical Trials/NCT01905449
NCT01905449
Completed
Phase 1

Biofeedback and Speech Disorders

Yale University1 site in 1 country35 target enrollmentMay 2013

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Speech Sound Disorders
Sponsor
Yale University
Enrollment
35
Locations
1
Primary Endpoint
Percent correct for target speech sound
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Children with speech sound disorders will receive speech therapy using real-time images of the tongue from ultrasound. These images will be used to cue the child to change the tongue position when producing speech sounds.

Registry
clinicaltrials.gov
Start Date
May 2013
End Date
July 2016
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Participants must be native English-speaking children with no known hearing or vision deficits. Participants must be within the specified age range and have been identified as having speech production difficulties by a local speech-language therapist.

Exclusion Criteria

  • Participants will be excluded if there is a history of oral structural impairment (e.g., cleft palate), hearing or vision impairment, history of neurological impairment or injury, developmental disabilities such as Down Syndrome or Autism, or intellectual disability.
  • During initial testing, participants must score below a standard score of 75 on the Goldman-Fristoe Test of Articulation-2 and also score below 20% accurate on a probe list of words assessing accuracy of the /r/ sound

Outcomes

Primary Outcomes

Percent correct for target speech sound

Time Frame: Change in accuracy after 7 one-hour treatment sessions (3.5 weeks), and after 14 one-hour treatment sessions (7 weeks)

Study Sites (1)

Loading locations...

Similar Trials